>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Selasa, 10 Februari 2009

Indo Premier BMRI Rp.1,770 – SELL

On Friday, February 6th 2009, BMRI hold analyst meeting which is attended by company BOD and some its general manager to discuss company performance in 2009 and further disclosure about company risk management. The company have not released 2008 audited figure yet and will be announced it in late march 2009. The company mostly talked about BMRI risk management system, so it isn’t affect significantly to our valuation model.

As our prediction before, the state owned bank benefited by increasing third party fund which was came from small and private bank’s origin fund worrying about banks liquidation. Unlike BBCA which has source of fund from retail and small business, The banks third party funds mostly come from whole sale (wealthy person and corporate client) which was more sensitive to interest compare to retail client. Its client mostly prefer to switch their saving deposit account to time deposit account because of interest rate increasing climate. As the consequence, BMRI’s CASA ratio decline from 59% in Q3 2008 to 57% in FY 2008.

Based on company data, we revised some of our assumption in our valuation especially about credit and third party fund (TPF) in 2008. Because of change in data, we reduced BMRI EPS in 2009 by 15.29 from early asumption to Rp. 216. Decreasing NIM potentially and increasing NPL will be BMRI major issue in the ox year. We maintain our SELL recommendation with TP Rp. 1.226 (Previously Rp. 1.136), which calculated based on Devidend Discount Model.

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News